A detailed history of Sunpointe, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sunpointe, LLC holds 6,734 shares of NVO stock, worth $572,390. This represents 0.66% of its overall portfolio holdings.

Number of Shares
6,734
Previous 6,929 2.81%
Holding current value
$572,390
Previous $989 Million 18.93%
% of portfolio
0.66%
Previous 0.64%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$119.07 - $145.42 $23,218 - $28,356
-195 Reduced 2.81%
6,734 $802 Million
Q2 2024

Jul 19, 2024

BUY
$122.71 - $146.91 $21,106 - $25,268
172 Added 2.55%
6,929 $989 Million
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $37,984 - $50,562
372 Added 5.83%
6,757 $874 Million
Q4 2023

Feb 20, 2024

BUY
$87.78 - $105.45 $560,475 - $673,298
6,385 New
6,385 $661 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sunpointe, LLC Portfolio

Follow Sunpointe, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunpointe, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunpointe, LLC with notifications on news.